AQR Capital Management - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 61 filers reported holding RECRO PHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q2 2021$46,000
-52.6%
19,996
-42.4%
0.00%
Q1 2021$97,000
-75.4%
34,688
-81.5%
0.00%
-100.0%
Q3 2020$394,000
-69.2%
187,748
-33.1%
0.00%
-50.0%
Q2 2020$1,278,000
+191.1%
280,772
+422.7%
0.00%
+100.0%
Q1 2020$439,000
+10.0%
53,720
+146.6%
0.00%
Q4 2019$399,000
+110.0%
21,786
+27.0%
0.00%
Q3 2019$190,00017,1610.00%
Other shareholders
RECRO PHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
Samjo Capital LLC 8,039,100$3,770,3381.48%
First Light Asset Management, LLC 19,676,396$9,228,2300.88%
AWM Investment Company, Inc. 10,266,144$4,814,8220.71%
Caligan Partners LP 1,689,768$794,1910.36%
HighMark Wealth Management LLC 484,985$227,4580.19%
Nantahala Capital Management 1,250,000$586,2500.05%
Clear Harbor Asset Management, LLC 938,847$440,3190.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,249,229$1,992,8880.03%
TITLEIST ASSET MANAGEMENT, LLC 210,148$98,5590.02%
ROYCE & ASSOCIATES LP 3,285,082$1,540,7030.02%
View complete list of RECRO PHARMA INC shareholders